The 24-month results of the COMFORT Peripheral Nerve Stimulation (PNS) RCT were published on January 23, 2026 in the peer-reviewed journal Chronic Pain & Management and are available here. These ...

Nalu Advances Wearable Neurostimulation with New, 39% Smaller Therapy Disc Nalu Medical Inc., announced the release of a next-generation Therapy Disc—a significantly smaller, lighter and more ...

Proceeds will accelerate commercial growth and expand clinical and health-economic evidence for the innovative Nalu neurostimulation system featuring the revolutionary micro-IPG.™ Series E round led ...

At 3 months, in the COMFORT 2 Active Arm, there was an 80% responder rate where responders achieved at least 50% pain relief, and there was an average pain reduction of 66% (p<0.001) compared to a 4% ...

Nalu Medical has collected $65 million in new financing to boost the reach and adoption of its miniaturized neurostimulation implant aimed at treating chronic pain. The California-based company’s ...

Runway's Flexible Growth Capital Will Aid In The Commercialization Of Nalu Medical's Neuromodulation Devices To Relieve Chronic Neuropathic Pain WOODSIDE, Calif., Oct. 20, 2022 /PRNewswire/ -- Runway ...

Boston Scientific Corp. moved to acquire the balance of Nalu Medical Inc. in a $533 million cash deal, expanding its chronic pain portfolio with the addition of peripheral nerve stimulation. The Nalu ...

PHOENIX, Sept. 16, 2025 /PRNewswire/ -- Trinity Capital Inc (TRIN). (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of up to $50 million in growth ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, announced today the ...